Advertisement
Product › Details
Oncotype DX™ Breast Cancer Assay
Next higher product group | pharmacogenomic/pharmacogenetic cancer test | |
Status | 2004-01-01 sales start | |
Organisation | Genomic Health Inc. (Nasdaq: GHDX) | |
Group | Exact Sciences (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for Oncotype DX™ Breast Cancer Assay
- [1] Exact Sciences Corporation. (7/29/19). "Press Release: Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company". Madison, WI & Redwood City, CA....
- [2] Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen....
- [3] BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz....
- [4] Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top